Santhera Pharmaceuticals

When it comes to diagnosing Duchenne muscular dystrophy (DMD) every day counts. That’s because earlier diagnosis also means: 🔜 Earlier access to support networks 🔜 Earlier access to management options 🔜 Earlier opportunities to start treatment — vital to slowing disease progression   If you have any concerns about your child’s development, your pediatrician will be able to offer the advice you need.   #DuchenneMuscularDystrophy #Santhera #TheirFutureOurFocus #DMD

Strength is also about resilience in the face of adversity. To all those battling DMD, your courage and unwavering spirit are a beacon of hope for the community and for us at Santhera. Keep fighting, keep believing, because every day you inspire us to do more.💙 #DuchenneMuscularDystrophy #DMDWarriors #CourageousHearts #Santhera #TheirFutureOurFocus #DMD

International Self-Care Day, celebrated on July 24th, highlights the significance of taking proactive measures for your health and well-being. Whether you are a healthcare professional, a patient caregiver or someone living with a rare disease, self-care can help you lead a healthy and fulfilling life.   Here are some practical self-care tips to integrate into your day-to-day: 😴 Get Enough Sleep: Aim for 7-9 hours of sleep each night to support your body’s recovery and mental sharpness. 💧 Hydrate Regularly: Drink at least 8 glasses of water a day to keep your body hydrated and your systems functioning well. 🥗 Eat Nutritiously: Focus on a balanced diet rich in nutrients, including plenty of fruits, vegetables, lean proteins, and whole grains. 🏃 Stay Active: Engage in physical activities you enjoy to keep your body strong and your mind clear. 🧠 Take Mental Breaks: Incorporate moments of relaxation and mindfulness into your routine to manage stress and enhance your mental health. 🩺 Health Monitoring: Keep up with regular health screenings and check-ups to stay on top of your health.   Self-care is a daily practice that leads to long-term health benefits. #InternationalSelfCareDay #SelfCare #Wellbeing #HealthyLifeStyle #Santhera #TheirFutureOurFocus #DMD

We want to shine a spotlight on the incredible caregivers in the Duchenne muscular dystrophy community. YOU make a world of difference in the lives of those you care for. Whether it's providing round-the-clock support, advocating for better care, or simply being a source of compassion and encouragement, your dedication is unmatched. From Santhera, we thank you for your tireless efforts and the profound impact you make each day. 👏🏻 #DMDCaregivers #Duchennemusculardystrophy #Santhera #TheirFutureOurFocus #DMD

July 5th marks Research Appreciation Day. We want to extend our gratitude to the dedicated researchers tirelessly working towards advancements in DMD. Your passion, innovation, and commitment to unraveling the complexities of this condition drive much needed progress in the field. Your groundbreaking discoveries pave the way for improved treatments, better care, and ultimately, a brighter future for individuals and families affected by DMD. 🩺 💙   Discover how Santhera is shaping the future of DMD at santhera.com #ResearchAppreciationDay #DMDResearch #Gratitude #Duchennemusculardystrophy #Santhera #TheirFutureOurFocus #DMD

Did you know that early diagnosis of Duchenne muscular dystrophy (DMD) can significantly impact the quality of life and treatment options for those affected? Early intervention is crucial. Why Early Diagnosis is Important: 🩺 Early treatment can slow disease progression 🔧 Early therapies improve mobility 🏫 Access to essential support services What You Can Do: 👀 Observe your child's development 🗣️ Discuss any concerns with your pediatrician Early diagnosis means early treatment and access to support. 💙 #DuchenneMuscularDystrophy #EarlyDiagnosis #DuchenneAwareness #Santhera#FightDMD #AwarenessMatters #TheirFutureOurFocus #DMD

Yesterday, following the new financing announcement, we held a conference call to update the investment community. The call was moderated by Joris Zimmermann, Research Analyst Healthcare with Octavian AG, who invited Santhera's CEO Dario Eklund, CFO Andrew Smith, and CMO Shabir Hasham, MD, to discuss recent developments and prospects. -- You missed it? Here you can access the replay https://bit.ly/3XzJs6n #Santhera #theirfutureourfocus

Today, Santhera announced financing taking the Company to cash flow break-even! – “We are very pleased to have achieved significant financing goals for Santhera and our shareholders through these initiatives. The new financing is non-dilutive to shareholders, the royalty monetization is partial and capped, leaving upside potential to Santhera, and the debt repayment schedule aligns well with our growth expectations,” said Andrew Smith, Chief Financial Officer of Santhera. “Importantly, it addresses our near-term debt obligations and provides us with sufficient funding to drive market launches and growth of AGAMREE in Europe and to pursue additional development programs for AGAMREE.” Read our press release at https://bit.ly/3Rx4Qpg #Santhera #theirfutureourfocus

WE SAY THANK YOU! -- Santhera Pharmaceuticals’ shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held yesterday in Pratteln (Switzerland) with a large majority. Participating shareholders represented a total of 4,535,785 shares or 35.9% of the Company’s share capital. For more please read our press release at https://bit.ly/3VPV0QH. #Santhera #theirfutureourfocus

Today, Santhera announced financing taking the Company to cash flow break-even! – “We are very pleased to have achieved significant financing goals for Santhera and our shareholders through these initiatives. The new financing is non-dilutive to shareholders, the royalty monetization is partial and capped, leaving upside potential to Santhera, and the debt repayment schedule aligns well with our growth expectations,” said Andrew Smith, Chief Financial Officer of Santhera. “Importantly, it addresses our near-term debt obligations and provides us with sufficient funding to drive market launches and growth of AGAMREE in Europe and to pursue additional development programs for AGAMREE.” Read our press release at https://bit.ly/3Rx4Qpg #Santhera #theirfutureourfocus